Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy.

@article{Mehran2014TumorEM,
  title={Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy.},
  author={Reza John Mehran and Monique B Nilsson and Mehrdad Khajavi and Zhiqiang Du and Tina Cascone and Hua Kang Wu and Andrea Carolina Cort{\'e}s and Li Xu and Amado J. Zurita and Robert Schier and Bernhard J c j Riedel and Randa El-Zein and John V. Heymach},
  journal={Cancer research},
  year={2014},
  volume={74 10},
  pages={2731-41}
}
Circulating endothelial cells (CEC) are derived from multiple sources, including bone marrow (circulating endothelial progenitors; CEP), and established vasculature (mature CEC). Although CECs have shown promise as a biomarker for patients with cancer, their utility has been limited, in part, by the lack of specificity for tumor vasculature and the… CONTINUE READING